A citation-based method for searching scientific literature

J Jiménez-Villegas, L Ferraiuolo, R J Mead, P J Shaw, A Cuadrado, A I Rojo. Free Radic Biol Med 2021
Times Cited: 6







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.
Jochen H Weishaupt, Claudia Bartels, Esther Pölking, Jeannine Dietrich, Gundula Rohde, Burkhard Poeggeler, Nina Mertens, Swetlana Sperling, Matthias Bohn, Gerald Hüther,[...]. J Pineal Res 2006
187
33

Decoding ALS: from genes to mechanism.
J Paul Taylor, Robert H Brown, Don W Cleveland. Nature 2016
33


Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis.
G Y Wang, S L Rayner, R Chung, B Y Shi, X J Liang. Mater Today Bio 2020
23
33

Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention.
Teresa Cunha-Oliveira, Liliana Montezinho, Catarina Mendes, Omidreza Firuzi, Luciano Saso, Paulo J Oliveira, Filomena S G Silva. Oxid Med Cell Longev 2020
26
33

Secondary Metabolites with Antioxidant Activities for the Putative Treatment of Amyotrophic Lateral Sclerosis (ALS): "Experimental Evidences".
Jamire M Silva, Michelangela S C Nobre, Sonaly L Albino, Lucas L Lócio, Agnis P S Nascimento, Luciana Scotti, Marcus T Scotti, João A Oshiro-Junior, Maria C A Lima, Francisco J B Mendonça-Junior,[...]. Oxid Med Cell Longev 2020
5
40

Molecular and Cellular Mechanisms Affected in ALS.
Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya Geetha Vijayakumar, William J Duddy, Stephanie Duguez. J Pers Med 2020
43
33

Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.
A Chiò, G Logroscino, B J Traynor, J Collins, J C Simeone, L A Goldstein, L A White. Neuroepidemiology 2013
427
33

miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients.
Bruna De Felice, Anna Annunziata, Giuseppe Fiorentino, Marco Borra, Elio Biffali, Cinzia Coppola, Roberto Cotrufo, Johannes Brettschneider, Maria Luisa Giordana, Tamas Dalmay,[...]. Neurogenetics 2014
74
33

Cerebrovascular and Neurological Disorders: Protective Role of NRF2.
Farzane Sivandzade, Aditya Bhalerao, Luca Cucullo. Int J Mol Sci 2019
43
33


Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis.
Marcelo R Vargas, Delinda A Johnson, Daniel W Sirkis, Albee Messing, Jeffrey A Johnson. J Neurosci 2008
314
33

Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients.
N Shibata, R Nagai, K Uchida, S Horiuchi, S Yamada, A Hirano, M Kawaguchi, T Yamamoto, S Sasaki, M Kobayashi. Brain Res 2001
166
33

Association Between Dietary Intake and Function in Amyotrophic Lateral Sclerosis.
Jeri W Nieves, Chris Gennings, Pam Factor-Litvak, Jonathan Hupf, Jessica Singleton, Valerie Sharf, Björn Oskarsson, J Americo M Fernandes Filho, Eric J Sorenson, Emanuele D'Amico,[...]. JAMA Neurol 2016
51
33

A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases.
Sarmistha Saha, Brigitta Buttari, Elisabetta Profumo, Paolo Tucci, Luciano Saso. Front Cell Neurosci 2022
13
33

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases.
Antonio Cuadrado, Ana I Rojo, Geoffrey Wells, John D Hayes, Sharon P Cousin, William L Rumsey, Otis C Attucks, Stephen Franklin, Anna-Liisa Levonen, Thomas W Kensler,[...]. Nat Rev Drug Discov 2019
506
33

NRF2 as a Therapeutic Target in Neurodegenerative Diseases.
Mikah S Brandes, Nora E Gray. ASN Neuro 2020
100
33

Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development.
Natalia Robledinos-Antón, Raquel Fernández-Ginés, Gina Manda, Antonio Cuadrado. Oxid Med Cell Longev 2019
252
33

Improving efficiency of ALS clinical trials using lead-in designs.
Dan H Moore, Robert G Miller. Amyotroph Lateral Scler Other Motor Neuron Disord 2004
16
16

Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain.
Xiaoying Zhuang, Xiaoyu Xiang, William Grizzle, Dongmei Sun, Shuangqin Zhang, Robert C Axtell, Songwen Ju, Jiangyao Mu, Lifeng Zhang, Lawrence Steinman,[...]. Mol Ther 2011
801
16

Vitamin E intake and risk of amyotrophic lateral sclerosis.
Alberto Ascherio, Marc G Weisskopf, Eilis J O'reilly, Eric J Jacobs, Marjorie L McCullough, Eugenia E Calle, Merit Cudkowicz, Michael J Thun. Ann Neurol 2005
111
16

S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis.
Richard J Mead, Adrian Higginbottom, Scott P Allen, Janine Kirby, Ellen Bennett, Siân C Barber, Paul R Heath, Antonio Coluccia, Neelam Patel, Iain Gardner,[...]. Free Radic Biol Med 2013
45
16

Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
Yu-Ichi Noto, Kazumoto Shibuya, Steve Vucic, Matthew C Kiernan. Expert Rev Neurother 2016
14
16


Modeling ALS using iPSCs: is it possible to reproduce the phenotypic variations observed in patients in vitro?
Juliana Ferreira Vasques, Rosalia Mendez-Otero, Fernanda Gubert. Regen Med 2020
3
33

Prospective study of cigarette smoking and amyotrophic lateral sclerosis.
M G Weisskopf, M L McCullough, E E Calle, M J Thun, M Cudkowicz, A Ascherio. Am J Epidemiol 2004
102
16

Diagnostics of Amyotrophic Lateral Sclerosis: Up to Date.
Ivana Štětkářová, Edvard Ehler. Diagnostics (Basel) 2021
6
16

Detection of BMAA in the human central nervous system.
L Berntzon, L O Ronnevi, B Bergman, J Eriksson. Neuroscience 2015
36
16

Novel nanogels as drug delivery systems for poorly soluble anticancer drugs.
Na Li, Jinli Wang, Xingguo Yang, Lingbing Li. Colloids Surf B Biointerfaces 2011
29
16

Distinction of sporadic and familial forms of ALS based on mitochondrial characteristics.
Jarosław Walczak, Grażyna Dębska-Vielhaber, Stefan Vielhaber, Jędrzej Szymański, Agata Charzyńska, Jerzy Duszyński, Joanna Szczepanowska. FASEB J 2019
17
16

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
M E Gurney, F B Cutting, P Zhai, A Doble, C P Taylor, P K Andrus, E D Hall. Ann Neurol 1996
537
16

Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis.
Mireia Herrando-Grabulosa, Núria Gaja-Capdevila, José M Vela, Xavier Navarro. Br J Pharmacol 2021
20
16

The overlap of amyotrophic lateral sclerosis and frontotemporal dementia.
Catherine Lomen-Hoerth, Thomas Anderson, Bruce Miller. Neurology 2002
495
16

Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.
Weihua Zhao, David R Beers, Stanley H Appel. J Neuroimmune Pharmacol 2013
201
16

Edaravone, a radical scavenger, inhibits mitochondrial permeability transition pore in rat brain.
Yuko Takayasu, Junko Nakaki, Toshiyuki Kawasaki, Ken Koda, Yukio Ago, Akemichi Baba, Toshio Matsuda. J Pharmacol Sci 2007
28
16

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Manuela Neumann, Deepak M Sampathu, Linda K Kwong, Adam C Truax, Matthew C Micsenyi, Thomas T Chou, Jennifer Bruce, Theresa Schuck, Murray Grossman, Christopher M Clark,[...]. Science 2006
16

The natural history of primary lateral sclerosis.
P H Gordon, B Cheng, I B Katz, M Pinto, A P Hays, H Mitsumoto, L P Rowland. Neurology 2006
229
16

Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.
Melanie D Sweeney, Abhay P Sagare, Berislav V Zlokovic. Nat Rev Neurol 2018
16

Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS.
Wenhua Zhang, Malini Narayanan, Robert M Friedlander. Ann Neurol 2003
147
16

Informatics-assisted protein profiling in a transgenic mouse model of amyotrophic lateral sclerosis.
Thomas J Lukas, Wei Wei Luo, Haihong Mao, Natalie Cole, Teepu Siddique. Mol Cell Proteomics 2006
31
16

Electrospinning Nanofibers for Therapeutics Delivery.
S M Shatil Shahriar, Jagannath Mondal, Mohammad Nazmul Hasan, Vishnu Revuri, Dong Yun Lee, Yong-Kyu Lee. Nanomaterials (Basel) 2019
71
16


Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.
Hristelina Ilieva, Magdalini Polymenidou, Don W Cleveland. J Cell Biol 2009
747
16

Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders.
Caroline Vissers, Guo-Li Ming, Hongjun Song. Adv Drug Deliv Rev 2019
39
16


ER Dysfunction and Protein Folding Stress in ALS.
Soledad Matus, Vicente Valenzuela, Danilo B Medinas, Claudio Hetz. Int J Cell Biol 2013
70
16

The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis.
Stephanie R Shepheard, Tim Chataway, David W Schultz, Robert A Rush, Mary-Louise Rogers. PLoS One 2014
46
16

BMAA and Neurodegenerative Illness.
Paul Alan Cox, Richard M Kostrzewa, Gilles J Guillemin. Neurotox Res 2018
24
16

Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS).
Lindsay Poppe, Laura Rué, Wim Robberecht, Ludo Van Den Bosch. Exp Neurol 2014
40
16

Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.
Jennifer S Yokoyama, Celeste M Karch, Chun C Fan, Luke W Bonham, Naomi Kouri, Owen A Ross, Rosa Rademakers, Jungsu Kim, Yunpeng Wang, Günter U Höglinger,[...]. Acta Neuropathol 2017
55
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.